modelHaloperidol_Li2022_base

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:haloperidol
ATC code:N05AD01
model:one compartment, IV dosing (PK_1C)
source:Li L et al. 2022
population:critically ill adults with ICU delirium
measured compound:haloperidol
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
CL (L/h)54.6L/hCL
Vd (L)1450LV

About haloperidol

Haloperidol is an antipsychotic used to treat conditions such as schizophrenia, psychosis, delirium, Tourette syndrome, and vomiting. It is widely used and appears on the WHO list of essential medicines, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q251347 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Haloperidol.

References

  1. Li L et al. (2022). Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?. Pharmaceutics 14(3). DOI:10.3390/pharmaceutics14030549 PUBMED:35335925

Parameters

TypeNameDefaultDescription
RealCl_ref1.5166666666666667e-05Cl [m3/s]
RealVd_ref1.45Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Li_2022: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate